Global Age-related Macular Degeneration Market Insights and Forecast to 2028

Publisher Name :
Date: 12-Jan-2022
No. of pages: 114
Inquire Before Buying

Age-related Macular Degeneration market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Age-related Macular Degeneration market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Wet AMD

- Dry AMD

Segment by Application

- Drugstore

- Hospital

- Others

By Company

- Bayer HealthCare

- F. Hoffmann-La Roche

- Novartis

- Regeneron Pharmaceuticals

- Alcon

- Allergan

- Avalanche

- Bausch+Lomb

- Gilead Sciences

- Iconic Therapeutics

- Neurotech Pharmaceuticals

- Ohr Pharmaceutical

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Age-related Macular Degeneration Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-related Macular Degeneration Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Age-related Macular Degeneration Market Perspective (2017-2028)
2.2 Age-related Macular Degeneration Growth Trends by Region
2.2.1 Age-related Macular Degeneration Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Age-related Macular Degeneration Historic Market Size by Region (2017-2022)
2.2.3 Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028)
2.3 Age-related Macular Degeneration Market Dynamics
2.3.1 Age-related Macular Degeneration Industry Trends
2.3.2 Age-related Macular Degeneration Market Drivers
2.3.3 Age-related Macular Degeneration Market Challenges
2.3.4 Age-related Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-related Macular Degeneration Players by Revenue
3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2017-2022)
3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2017-2022)
3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
3.4 Global Age-related Macular Degeneration Market Concentration Ratio
3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2021
3.5 Age-related Macular Degeneration Key Players Head office and Area Served
3.6 Key Players Age-related Macular Degeneration Product Solution and Service
3.7 Date of Enter into Age-related Macular Degeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-related Macular Degeneration Breakdown Data by Type
4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2017-2022)
4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028)
5 Age-related Macular Degeneration Breakdown Data by Application
5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2017-2022)
5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Age-related Macular Degeneration Market Size (2017-2028)
6.2 North America Age-related Macular Degeneration Market Size by Type
6.2.1 North America Age-related Macular Degeneration Market Size by Type (2017-2022)
6.2.2 North America Age-related Macular Degeneration Market Size by Type (2023-2028)
6.2.3 North America Age-related Macular Degeneration Market Share by Type (2017-2028)
6.3 North America Age-related Macular Degeneration Market Size by Application
6.3.1 North America Age-related Macular Degeneration Market Size by Application (2017-2022)
6.3.2 North America Age-related Macular Degeneration Market Size by Application (2023-2028)
6.3.3 North America Age-related Macular Degeneration Market Share by Application (2017-2028)
6.4 North America Age-related Macular Degeneration Market Size by Country
6.4.1 North America Age-related Macular Degeneration Market Size by Country (2017-2022)
6.4.2 North America Age-related Macular Degeneration Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Age-related Macular Degeneration Market Size (2017-2028)
7.2 Europe Age-related Macular Degeneration Market Size by Type
7.2.1 Europe Age-related Macular Degeneration Market Size by Type (2017-2022)
7.2.2 Europe Age-related Macular Degeneration Market Size by Type (2023-2028)
7.2.3 Europe Age-related Macular Degeneration Market Share by Type (2017-2028)
7.3 Europe Age-related Macular Degeneration Market Size by Application
7.3.1 Europe Age-related Macular Degeneration Market Size by Application (2017-2022)
7.3.2 Europe Age-related Macular Degeneration Market Size by Application (2023-2028)
7.3.3 Europe Age-related Macular Degeneration Market Share by Application (2017-2028)
7.4 Europe Age-related Macular Degeneration Market Size by Country
7.4.1 Europe Age-related Macular Degeneration Market Size by Country (2017-2022)
7.4.2 Europe Age-related Macular Degeneration Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age-related Macular Degeneration Market Size (2017-2028)
8.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type
8.2.1 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Age-related Macular Degeneration Market Share by Type (2017-2028)
8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application
8.3.1 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Age-related Macular Degeneration Market Share by Application (2017-2028)
8.4 Asia-Pacific Age-related Macular Degeneration Market Size by Region
8.4.1 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Age-related Macular Degeneration Market Size (2017-2028)
9.2 Latin America Age-related Macular Degeneration Market Size by Type
9.2.1 Latin America Age-related Macular Degeneration Market Size by Type (2017-2022)
9.2.2 Latin America Age-related Macular Degeneration Market Size by Type (2023-2028)
9.2.3 Latin America Age-related Macular Degeneration Market Share by Type (2017-2028)
9.3 Latin America Age-related Macular Degeneration Market Size by Application
9.3.1 Latin America Age-related Macular Degeneration Market Size by Application (2017-2022)
9.3.2 Latin America Age-related Macular Degeneration Market Size by Application (2023-2028)
9.3.3 Latin America Age-related Macular Degeneration Market Share by Application (2017-2028)
9.4 Latin America Age-related Macular Degeneration Market Size by Country
9.4.1 Latin America Age-related Macular Degeneration Market Size by Country (2017-2022)
9.4.2 Latin America Age-related Macular Degeneration Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-related Macular Degeneration Market Size (2017-2028)
10.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type
10.2.1 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Age-related Macular Degeneration Market Share by Type (2017-2028)
10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application
10.3.1 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Age-related Macular Degeneration Market Share by Application (2017-2028)
10.4 Middle East & Africa Age-related Macular Degeneration Market Size by Country
10.4.1 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
11.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022)
11.1.5 Bayer HealthCare Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Age-related Macular Degeneration Introduction
11.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
11.4.5 Regeneron Pharmaceuticals Recent Developments
11.5 Alcon
11.5.1 Alcon Company Details
11.5.2 Alcon Business Overview
11.5.3 Alcon Age-related Macular Degeneration Introduction
11.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2017-2022)
11.5.5 Alcon Recent Developments
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Age-related Macular Degeneration Introduction
11.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2017-2022)
11.6.5 Allergan Recent Developments
11.7 Avalanche
11.7.1 Avalanche Company Details
11.7.2 Avalanche Business Overview
11.7.3 Avalanche Age-related Macular Degeneration Introduction
11.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022)
11.7.5 Avalanche Recent Developments
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Details
11.8.2 Bausch+Lomb Business Overview
11.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
11.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022)
11.8.5 Bausch+Lomb Recent Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
11.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022)
11.9.5 Gilead Sciences Recent Developments
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Details
11.10.2 Iconic Therapeutics Business Overview
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
11.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022)
11.10.5 Iconic Therapeutics Recent Developments
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Details
11.11.2 Neurotech Pharmaceuticals Business Overview
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
11.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
11.11.5 Neurotech Pharmaceuticals Recent Developments
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Details
11.12.2 Ohr Pharmaceutical Business Overview
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
11.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022)
11.12.5 Ohr Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age-related Macular Degeneration Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Age-related Macular Degeneration Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Age-related Macular Degeneration Market Share by Region (2017-2022)
Table 8. Global Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Age-related Macular Degeneration Market Share by Region (2023-2028)
Table 10. Age-related Macular Degeneration Market Trends
Table 11. Age-related Macular Degeneration Market Drivers
Table 12. Age-related Macular Degeneration Market Challenges
Table 13. Age-related Macular Degeneration Market Restraints
Table 14. Global Age-related Macular Degeneration Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Age-related Macular Degeneration Revenue Share by Players (2017-2022)
Table 16. Global Top Age-related Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Table 17. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age-related Macular Degeneration Product Solution and Service
Table 21. Date of Enter into Age-related Macular Degeneration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Age-related Macular Degeneration Revenue Market Share by Type (2017-2022)
Table 25. Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Age-related Macular Degeneration Revenue Market Share by Type (2023-2028)
Table 27. Global Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Age-related Macular Degeneration Revenue Share by Application (2017-2022)
Table 29. Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Age-related Macular Degeneration Revenue Share by Application (2023-2028)
Table 31. North America Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Age-related Macular Degeneration Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare Age-related Macular Degeneration Product
Table 64. Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 65. Bayer HealthCare Recent Developments
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Product
Table 69. F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Age-related Macular Degeneration Product
Table 74. Novartis Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Regeneron Pharmaceuticals Company Details
Table 77. Regeneron Pharmaceuticals Business Overview
Table 78. Regeneron Pharmaceuticals Age-related Macular Degeneration Product
Table 79. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 80. Regeneron Pharmaceuticals Recent Developments
Table 81. Alcon Company Details
Table 82. Alcon Business Overview
Table 83. Alcon Age-related Macular Degeneration Product
Table 84. Alcon Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 85. Alcon Recent Developments
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Age-related Macular Degeneration Product
Table 89. Allergan Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 90. Allergan Recent Developments
Table 91. Avalanche Company Details
Table 92. Avalanche Business Overview
Table 93. Avalanche Age-related Macular Degeneration Product
Table 94. Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 95. Avalanche Recent Developments
Table 96. Bausch+Lomb Company Details
Table 97. Bausch+Lomb Business Overview
Table 98. Bausch+Lomb Age-related Macular Degeneration Product
Table 99. Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 100. Bausch+Lomb Recent Developments
Table 101. Gilead Sciences Company Details
Table 102. Gilead Sciences Business Overview
Table 103. Gilead Sciences Age-related Macular Degeneration Product
Table 104. Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 105. Gilead Sciences Recent Developments
Table 106. Iconic Therapeutics Company Details
Table 107. Iconic Therapeutics Business Overview
Table 108. Iconic Therapeutics Age-related Macular Degeneration Product
Table 109. Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 110. Iconic Therapeutics Recent Developments
Table 111. Neurotech Pharmaceuticals Company Details
Table 112. Neurotech Pharmaceuticals Business Overview
Table 113. Neurotech Pharmaceuticals Age-related Macular Degeneration Product
Table 114. Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 115. Neurotech Pharmaceuticals Recent Developments
Table 116. Ohr Pharmaceutical Company Details
Table 117. Ohr Pharmaceutical Business Overview
Table 118. Ohr Pharmaceutical Age-related Macular Degeneration Product
Table 119. Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 120. Ohr Pharmaceutical Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2021 VS 2028
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-related Macular Degeneration Market Share by Application: 2021 VS 2028
Figure 5. Drugstore Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. Age-related Macular Degeneration Report Years Considered
Figure 9. Global Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Age-related Macular Degeneration Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Age-related Macular Degeneration Market Share by Region: 2021 VS 2028
Figure 12. Global Age-related Macular Degeneration Market Share by Players in 2021
Figure 13. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2021
Figure 15. North America Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 17. North America Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 18. North America Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 19. United States Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 23. Europe Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 24. Europe Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 25. Germany Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Age-related Macular Degeneration Market Size Share by Region (2017-2028)
Figure 35. China Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 45. Mexico Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 51. Turkey Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 57. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 58. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 59. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 60. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 61. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 62. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 63. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 64. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 65. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Three Way Stopcock Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 112
    Three Way Stopcock market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Three Way Stopcock market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Right Angle Type - T Type - Cross Type - Other Segment by A......
  • Global Laryngeal Mask Airway Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 118
    Laryngeal Mask Airway market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Laryngeal Mask Airway market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Adult - Children Segment by Application - Hospital - Clinic ......
  • Global Absorbable Sutures Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 107
    Absorbable Sutures market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Absorbable Sutures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Catgut - Polymer Chemistry - Collagen Suture - Other Segment by Applicati......
  • Global Mesotherapy Machine Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 110
    Mesotherapy Machine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Mesotherapy Machine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Negative Pressure Mesotherapy Machine - Ultrasonic Mesotherapy Machine - Resonance Mesotherap......
  • Global EEG Headset Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 108
    EEG Headset market is segmented by Type and by Application. Players, stakeholders, and other participants in the global EEG Headset market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Battery - Charge Segment by Application - Hospital - Pharmacy By Company......
  • Global 3D Medical Imaging Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 109
    3D Medical Imaging market is segmented by Type and by Application. Players, stakeholders, and other participants in the global 3D Medical Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - MRI 3D Images - Ultrasound 3D Images - Other Segment by Application - Hos......
  • Global Medicinal Oscillator Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 107
    Medicinal Oscillator market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medicinal Oscillator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Level Oscillation - Cyclotron Oscillation Segment by Application......
  • Global Manual External Defibrillator Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 89
    Manual External Defibrillator market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Manual External Defibrillator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Asynchronous External Defibrillator - Synchronous External Defibrillator ......
  • Global Chest Drainage Catheters Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 110
    Chest Drainage Catheters market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Chest Drainage Catheters market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Regular Chest Drainage Catheters - Thoracentesis Catheters - Others ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs